VERTEX PHARMACEUTICALS INC / MA Comprehensive Income
VERTEX PHARMACEUTICALS INC / MA (VRTX) reported Comprehensive Income of $1.12 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-04
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $1.12B, a 30.08% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $1.07B, a 82.77% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $1.24B, a 22.50% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $1.12B, a 6.45% increase year-over-year.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $3.81B.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$393.50M, a 110.92% decline from fiscal 2023.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $3.60B, a 9.00% increase from fiscal 2022.
- VERTEX PHARMACEUTICALS INC / MA comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $3.31B, a 36.28% increase from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.12B 10-Q · filed 2026-08-04 | $2.20B 10-Q · filed 2026-08-04 | $3.44B derived: sum of 3 quarters · filed 2026-08-04 | $4.55B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.07B 10-Q · filed 2026-05-05 | $2.31B derived: sum of 2 quarters · filed 2026-05-05 | $3.43B derived: sum of 3 quarters · filed 2026-05-05 | $4.29B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $1.24B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.36B derived: sum of 2 quarters · filed 2026-02-13 | $3.22B derived: sum of 3 quarters · filed 2026-08-04 | $3.81B 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | $1.12B 10-Q · filed 2025-11-04 | $1.98B derived: sum of 2 quarters · filed 2026-08-04 | $2.57B 10-Q · filed 2025-11-04 | $3.58B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $863.70M 10-Q · filed 2026-08-04 | $1.45B 10-Q · filed 2026-08-04 | $2.46B derived: sum of 3 quarters · filed 2026-08-04 | $3.51B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $586.60M 10-Q · filed 2026-05-05 | $1.60B derived: sum of 2 quarters · filed 2026-05-05 | $2.65B derived: sum of 3 quarters · filed 2026-05-05 | -$938.10M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $1.01B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.06B derived: sum of 2 quarters · filed 2026-02-13 | -$1.52B derived: sum of 3 quarters · filed 2026-02-13 | -$393.50M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | $1.05B 10-Q · filed 2025-11-04 | -$2.54B derived: sum of 2 quarters · filed 2025-11-04 | -$1.41B 10-Q · filed 2025-11-04 | -$448.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | -$3.59B 10-Q · filed 2025-08-05 | -$2.46B 10-Q · filed 2025-08-05 | -$1.50B derived: sum of 3 quarters · filed 2026-02-13 | -$427.60M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | $1.13B 10-Q · filed 2025-05-06 | $2.09B derived: sum of 2 quarters · filed 2026-02-13 | $3.16B derived: sum of 3 quarters · filed 2026-02-13 | $4.05B derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | $957.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $2.03B derived: sum of 2 quarters · filed 2026-02-13 | $2.92B derived: sum of 3 quarters · filed 2026-02-13 | $3.60B 10-K · filed 2026-02-13 | ||||
| 2023-09-30 | $1.07B 10-Q · filed 2024-11-05 | $1.96B derived: sum of 2 quarters · filed 2024-11-05 | $2.65B 10-Q · filed 2024-11-05 | $3.37B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-06-30 | $889.00M 10-Q · filed 2024-08-02 | $1.57B 10-Q · filed 2024-08-02 | $2.30B derived: sum of 3 quarters · filed 2025-02-13 | $3.27B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2023-03-31 | $685.90M 10-Q · filed 2024-05-07 | $1.41B derived: sum of 2 quarters · filed 2025-02-13 | $2.38B derived: sum of 3 quarters · filed 2025-02-13 | $3.24B derived: sum of 4 quarters · filed 2025-02-13 | ||||
| 2022-12-31 | $722.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.69B derived: sum of 2 quarters · filed 2025-02-13 | $2.55B derived: sum of 3 quarters · filed 2025-02-13 | $3.31B 10-K · filed 2025-02-13 | ||||
| 2022-09-30 | $970.60M 10-Q · filed 2023-11-07 | $1.83B derived: sum of 2 quarters · filed 2023-11-07 | $2.58B 10-Q · filed 2023-11-07 | $3.36B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-06-30 | $856.70M 10-Q · filed 2023-08-02 | $1.61B 10-Q · filed 2023-08-02 | $2.39B derived: sum of 3 quarters · filed 2024-02-15 | $3.28B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2022-03-31 | $757.50M 10-Q · filed 2023-05-02 | $1.53B derived: sum of 2 quarters · filed 2024-02-15 | $2.42B derived: sum of 3 quarters · filed 2024-02-15 | $2.50B derived: sum of 4 quarters · filed 2024-02-15 | ||||
| 2021-12-31 | $774.50M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $1.66B derived: sum of 2 quarters · filed 2024-02-15 | $1.74B derived: sum of 3 quarters · filed 2024-02-15 | $2.43B 10-K · filed 2024-02-15 | ||||
| 2021-09-30 | $888.60M 10-Q · filed 2022-10-28 | $888.62M 10-Q · filed 2021-11-03 | $963.70M derived: sum of 2 quarters · filed 2022-10-28 | $1.65B 10-Q · filed 2022-10-28 | $1.65B 10-Q · filed 2021-11-03 | $2.23B derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-06-30 | $75.10M 10-Q · filed 2022-08-05 | $75.07M 10-Q · filed 2021-07-30 | $763.40M 10-Q · filed 2022-08-05 | $763.38M 10-Q · filed 2021-07-30 | $1.34B derived: sum of 3 quarters · filed 2023-02-10 | $1.98B derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-03-31 | $688.30M 10-Q · filed 2022-05-06 | $688.32M 10-Q · filed 2021-04-30 | $1.27B derived: sum of 2 quarters · filed 2023-02-10 | $1.91B derived: sum of 3 quarters · filed 2023-02-10 | $2.72B derived: sum of 4 quarters · filed 2023-02-10 | |||
| 2020-12-31 | $576.75M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $1.22B derived: sum of 2 quarters · filed 2023-02-10 | $2.03B derived: sum of 3 quarters · filed 2023-02-10 | $2.65B 10-K · filed 2023-02-10 | $2.65B 10-K · filed 2021-02-11 | |||
| 2020-09-30 | $640.57M 10-Q · filed 2021-11-03 | $1.45B derived: sum of 2 quarters · filed 2021-11-03 | $2.07B 10-Q · filed 2021-11-03 | $2.63B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-06-30 | $809.77M 10-Q · filed 2021-07-30 | $1.43B 10-Q · filed 2021-07-30 | $1.99B derived: sum of 3 quarters · filed 2022-02-09 | $2.07B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2020-03-31 | $618.11M 10-Q · filed 2021-04-30 | $1.18B derived: sum of 2 quarters · filed 2022-02-09 | $1.26B derived: sum of 3 quarters · filed 2022-02-09 | $1.52B derived: sum of 4 quarters · filed 2022-02-09 | ||||
| 2019-12-31 | $562.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $641.90M derived: sum of 2 quarters · filed 2022-02-09 | $900.13M derived: sum of 3 quarters · filed 2022-02-09 | $1.17B 10-K · filed 2022-02-09 | $1.17B 10-K · filed 2020-02-13 | |||
| 2019-09-30 | $79.57M 10-Q · filed 2020-10-30 | $337.79M derived: sum of 2 quarters · filed 2020-10-30 | $611.76M 10-Q · filed 2020-10-30 | $2.16B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | $258.23M 10-Q · filed 2020-07-31 | $532.20M 10-Q · filed 2020-07-31 | $2.08B derived: sum of 3 quarters · filed 2021-02-11 | $2.22B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | $273.97M 10-Q · filed 2020-05-01 | $1.82B derived: sum of 2 quarters · filed 2021-02-11 | $1.96B derived: sum of 3 quarters · filed 2021-02-11 | $2.20B derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $1.55B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $1.68B derived: sum of 2 quarters · filed 2021-02-11 | $1.93B derived: sum of 3 quarters · filed 2021-02-11 | $2.13B 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | $133.66M 10-Q · filed 2019-10-31 | $376.16M derived: sum of 2 quarters · filed 2019-10-31 | $582.37M 10-Q · filed 2019-10-31 | $696.61M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | $242.50M 10-Q · filed 2019-08-01 | $448.71M 10-Q · filed 2019-08-01 | $562.95M derived: sum of 3 quarters · filed 2020-02-13 | $456.62M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | $206.21M 10-Q · filed 2019-05-01 | $320.45M derived: sum of 2 quarters · filed 2020-02-13 | $214.13M derived: sum of 3 quarters · filed 2020-02-13 | $194.34M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $114.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $7.91M derived: sum of 2 quarters · filed 2020-02-13 | -$11.87M derived: sum of 3 quarters · filed 2020-02-13 | $230.74M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$106.33M 10-Q · filed 2018-10-25 | -$126.11M derived: sum of 2 quarters · filed 2018-10-25 | $116.50M 10-Q · filed 2018-10-25 | $174.46M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-06-30 | -$19.78M 10-Q · filed 2018-07-26 | $222.83M 10-Q · filed 2018-07-26 | $280.79M derived: sum of 3 quarters · filed 2019-02-13 | $241.49M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2017-03-31 | $242.61M 10-Q · filed 2018-04-27 | $300.57M derived: sum of 2 quarters · filed 2019-02-13 | $261.27M derived: sum of 3 quarters · filed 2019-02-13 | $198.26M derived: sum of 4 quarters · filed 2019-02-13 | ||||
| 2016-12-31 | $57.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | $18.67M derived: sum of 2 quarters · filed 2019-02-13 | -$44.35M derived: sum of 3 quarters · filed 2019-02-13 | -$92.70M 10-K · filed 2019-02-13 | ||||
| 2016-09-30 | -$39.30M 10-Q · filed 2017-10-30 | -$102.31M derived: sum of 2 quarters · filed 2017-10-30 | -$150.67M 10-Q · filed 2017-10-30 | -$224.08M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-06-30 | -$63.02M 10-Q · filed 2017-07-28 | -$111.37M 10-Q · filed 2017-07-28 | -$184.79M derived: sum of 3 quarters · filed 2018-02-15 | -$276.72M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2016-03-31 | -$48.35M 10-Q · filed 2017-04-28 | -$121.77M derived: sum of 2 quarters · filed 2018-02-15 | -$213.70M derived: sum of 3 quarters · filed 2018-02-15 | -$405.05M derived: sum of 4 quarters · filed 2018-02-15 | ||||
| 2015-12-31 | -$73.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$165.35M derived: sum of 2 quarters · filed 2018-02-15 | -$356.69M derived: sum of 3 quarters · filed 2018-02-15 | -$555.43M 10-K · filed 2018-02-15 | ||||
| 2015-09-30 | -$91.93M 10-Q · filed 2016-10-31 | -$283.28M derived: sum of 2 quarters · filed 2016-10-31 | -$482.01M 10-Q · filed 2016-10-31 | -$658.91M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | -$191.35M 10-Q · filed 2016-08-01 | -$390.08M 10-Q · filed 2016-08-01 | -$566.98M derived: sum of 3 quarters · filed 2017-02-23 | -$735.85M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | -$198.73M 10-Q · filed 2016-05-03 | -$375.63M derived: sum of 2 quarters · filed 2017-02-23 | -$544.51M derived: sum of 3 quarters · filed 2017-02-23 | -$703.62M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$176.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$345.78M derived: sum of 2 quarters · filed 2017-02-23 | -$504.88M derived: sum of 3 quarters · filed 2017-02-23 | -$737.33M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$168.88M 10-Q · filed 2015-10-30 | -$327.98M derived: sum of 2 quarters · filed 2015-10-30 | -$560.43M 10-Q · filed 2015-10-30 | -$758.42M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-06-30 | -$159.11M 10-Q · filed 2015-08-04 | -$391.56M 10-Q · filed 2015-08-04 | -$589.55M derived: sum of 3 quarters · filed 2016-02-16 | -$713.00M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2014-03-31 | -$232.45M 10-Q · filed 2015-05-04 | -$430.44M derived: sum of 2 quarters · filed 2016-02-16 | -$553.89M derived: sum of 3 quarters · filed 2016-02-16 | -$611.14M derived: sum of 4 quarters · filed 2016-02-16 | ||||
| 2013-12-31 | -$197.99M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-16 | -$321.44M derived: sum of 2 quarters · filed 2016-02-16 | -$378.69M derived: sum of 3 quarters · filed 2016-02-16 | -$687.31M 10-K · filed 2016-02-16 | -$444.78M 10-K · filed 2014-02-11 | |||
| 2013-09-30 | -$123.45M 10-Q · filed 2014-11-06 | -$180.70M derived: sum of 2 quarters · filed 2014-11-06 | -$489.31M 10-Q · filed 2014-11-06 | -$509.70M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-06-30 | -$57.25M 10-Q · filed 2014-07-31 | -$365.86M 10-Q · filed 2014-07-31 | -$386.25M derived: sum of 3 quarters · filed 2015-02-13 | -$443.53M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2013-03-31 | -$308.62M 10-Q · filed 2014-05-05 | -$329.00M derived: sum of 2 quarters · filed 2015-02-13 | -$386.29M derived: sum of 3 quarters · filed 2015-02-13 | -$451.26M derived: sum of 4 quarters · filed 2015-02-13 | ||||
| 2012-12-31 | -$20.39M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$77.67M derived: sum of 2 quarters · filed 2015-02-13 | -$142.65M derived: sum of 3 quarters · filed 2015-02-13 | -$50.63M 10-K · filed 2015-02-13 | -$106.53M 10-K · filed 2013-03-01 | |||
| 2012-09-30 | -$57.29M 10-Q · filed 2013-11-07 | -$122.26M derived: sum of 2 quarters · filed 2013-11-07 | -$30.25M 10-Q · filed 2013-11-07 | $128.27M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-06-30 | -$64.98M 10-Q · filed 2013-08-02 | $27.04M 10-Q · filed 2013-08-02 | $185.56M derived: sum of 3 quarters · filed 2014-02-11 | $406.43M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2012-03-31 | $92.02M 10-Q · filed 2013-05-08 | $250.54M derived: sum of 2 quarters · filed 2014-02-11 | $471.41M derived: sum of 3 quarters · filed 2014-02-11 | $297.26M derived: sum of 4 quarters · filed 2014-02-11 | ||||
| 2011-12-31 | $158.52M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-11 | $379.39M derived: sum of 2 quarters · filed 2014-02-11 | $205.25M derived: sum of 3 quarters · filed 2014-02-11 | $29.59M 10-K · filed 2014-02-11 | ||||
| 2011-09-30 | $220.87M 10-Q · filed 2012-11-06 | $46.73M derived: sum of 2 quarters · filed 2012-11-06 | -$128.93M 10-Q · filed 2012-11-06 | -$309.71M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-06-30 | -$174.14M 10-Q · filed 2012-08-08 | -$349.81M 10-Q · filed 2012-08-08 | -$530.59M derived: sum of 3 quarters · filed 2013-03-01 | -$739.66M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2011-03-31 | -$175.66M 10-Q · filed 2012-05-10 | -$356.44M derived: sum of 2 quarters · filed 2013-03-01 | -$565.52M derived: sum of 3 quarters · filed 2013-03-01 | -$765.00M derived: sum of 4 quarters · filed 2013-03-01 | ||||
| 2010-12-31 | -$180.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$389.86M derived: sum of 2 quarters · filed 2013-03-01 | -$589.34M derived: sum of 3 quarters · filed 2013-03-01 | -$755.05M 10-K · filed 2013-03-01 | ||||
| 2010-09-30 | -$209.08M 10-Q · filed 2011-11-03 | -$408.56M derived: sum of 2 quarters · filed 2011-11-03 | -$574.27M 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | -$199.48M 10-Q · filed 2011-08-09 | -$365.19M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |